tES Modalities for the Treatment of ADHD

Last updated: May 8, 2025
Sponsor: The National Brain Mapping Laboratory (NBML)
Overall Status: Active - Recruiting

Phase

N/A

Condition

Tic Disorders

Autism

Holoprosencephaly

Treatment

transcranial electrical stimulation

Clinical Study ID

NCT06974136
IPM-NDD
  • Ages 7-18
  • All Genders

Study Summary

This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of ADHD by a licensed psychiatrist and a behavioral checklist

  • being 7-18 years old

  • providing written informed consent signed by parents

Exclusion

Exclusion Criteria:

  • comorbidity with other neurodevelopmental disorders

  • Comorbidity with other neurological disorders

  • previous history of neurosurgery

  • Presence of any ferromagnetic metal in the head

  • implanted medical devices in the head or neck region

  • history of non-controlled epilepsy with seizures in the last year

Study Design

Total Participants: 45
Treatment Group(s): 1
Primary Treatment: transcranial electrical stimulation
Phase:
Study Start date:
March 30, 2025
Estimated Completion Date:
July 01, 2026

Study Description

This project aims to evaluate the therapeutic potential of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), as innovative, non-invasive interventions for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. ADHD is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity that impair daily functioning. Conventional treatments, such as pharmacological interventions and behavioral therapies, may have limitations, including side effects or variable efficacy, prompting the exploration of neuromodulation techniques like tES.

Connect with a study center

  • Institute for Research in Fundamental Sciences

    Tehran,
    Iran, Islamic Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.